Innovative. Growing. Diversified. Committed to You.

For more than 70 years, Mission Pharmacal® Company (“Mission”) has been improving the lives of families, through every stage of life, with innovative, high-quality products. We are leaders in the therapeutic areas of women’s health, urology, pediatrics, and dermatology offering prescription and consumer products. We also work closely with a growing list of primary care physicians and those in long-term care settings.

In recent years, growth at Mission has meant more than expanding and improving the drug products the company offers. Today, the Mission Family of Companies provides a comprehensive portfolio of product and service offerings that help Mission and other pharmaceutical companies more effectively deliver needed prescription and consumer products into the hands of physicians, pharmacists, and, ultimately, patients.

Offerings include:

  • Research and development
  • Manufacturing
  • Packaging
  • Warehousing, fulfillment, and distribution
  • Sales force implementation and specialty sales support
  • Marketing
  • Generics
  • International partnerships

At first glance, the diversification that has resulted is a departure from Mission’s early years, yet the core founding principle of delivering the absolute best quality prescription and consumer products to the hands of patients remains unchanged.

Mission Pharmacal

Year Founded
1946
Specialization
We are a privately held pharmaceutical company that identifies unmet healthcare needs. We then meet those needs, either through Mission or one of our Family of Companies, by delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products. In so doing, we use only the purest ingredients and state-of-the-art methods of manufacturing.
Leadership
Bennett Kennedy
Bennett Kennedy
Sr. VP Corporate Development/Strategy
Partnership Inquiries

o: 210.696.8400
e: bennett.kennedy@missionpharmacal.com

Generic Pharmaceuticals Provider

BioComp Pharma®, Inc. (“BioComp”) is uniquely positioned to prosper in the ultra-competitive and increasingly generics-driven pharmaceutical industry. Through our experienced leadership team and exceptional core capabilities, we are poised for further growth and success with our continued addition of select partners and an active research and development pipeline. In addition, we offer services to other companies lacking the commercial and distribution infrastructure to bring a generic drug to market. Our team’s extensive pharmaceutical experience, coupled with low overhead costs and flexible operations, means we can distribute your products quickly with maximum profitability. 

Our complete turnkey and a la carte generics commercialization services include:

  • Labeling coordination and printing
  • Secure, environmentally controlled warehousing
  • Fully-licensed U.S. distribution and commercial launch
  • Electronic data interchange (EDI) capabilities 
  • National account and sales
    management and marketing
  • Accounting

Assurance of quality is paramount, so we only distribute products that are developed and manufactured in strict accordance with current Good Manufacturing Practice (cGMP) regulations.

BioComp Pharma

Year Founded
2008
Specialization
Focused on the development, sourcing, and commercialization of prescription generic drugs. We also specialize in offering these services to strategic partners, providing the full range of services in a flexible format to companies looking for commercial solutions.
Leadership
Pete Valko
Pete Valko
Chief Operating Officer
Partnership Inquiries

e: pvalko@biocomppharma.com
e: busdev@biocomppharma.com

Industry Leader In Transdermal Technology

ProSolus®, Inc. (“ProSolus”) has significantly improved the wearability of transdermal patches, offering more desirable, compact sizes that stay in place while working effectively. Few therapies on the market today are as effective or easy to use as ProSolus’ noninvasive and comfortable transdermal patches. Our state-of-the-art development and testing facility is capable of producing more than 10 million patches per year, and our primary focus lies in Pressure Sensitive Adhesive (PSA) technology and novel Hydrogel technology.

The ProSolus formulation team holds more than 35 patents in the transdermal and topical technology space and we have a proven track record of product commercialization. We are actively seeking strategic partnerships to out-license products and/or provide resources to commercialize products through:

  • Custom blending
  • Coating
  • Slitting
  • Die-cutting
  • Packaging
  • Full testing of products

Prosolus

Year Founded
2015
Specialization
Offers unrivaled expertise in the development and manufacturing of sophisticated and convenient transdermal/topical drug delivery systems (TDDS).
Leadership
Juan Mantelle
Juan Mantelle
Chief Operating Officer
Partnership Inquiries

o: 305.514.0271
c: 305.772.6652
e: jmantelle@prosoluspharma.com

Innovative. Growing. Diversified. Committed to You.

For more than 70 years, Mission Pharmacal® Company (“Mission”) has been improving the lives of families, through every stage of life, with innovative, high-quality products. We are leaders in the therapeutic areas of women’s health, urology, pediatrics, and dermatology offering prescription and consumer products. We also work closely with a growing list of primary care physicians and those in long-term care settings.

In recent years, growth at Mission has meant more than expanding and improving the drug products the company offers. Today, the Mission Family of Companies provides a comprehensive portfolio of product and service offerings that help Mission and other pharmaceutical companies more effectively deliver needed prescription and consumer products into the hands of physicians, pharmacists, and, ultimately, patients.

Offerings include:

  • Research and development
  • Manufacturing
  • Packaging
  • Warehousing, fulfillment, and distribution
  • Sales force implementation and specialty sales support
  • Marketing
  • Generics
  • International partnerships

At first glance, the diversification that has resulted is a departure from Mission’s early years, yet the core founding principle of delivering the absolute best quality prescription and consumer products to the hands of patients remains unchanged.

Mission Pharmacal

Year Founded
1946
Specialization
We are a privately held pharmaceutical company that identifies unmet healthcare needs. We then meet those needs, either through Mission or one of our Family of Companies, by delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products. In so doing, we use only the purest ingredients and state-of-the-art methods of manufacturing.
Leadership
Bennett Kennedy
Bennett Kennedy
Sr. VP Corporate Development/Strategy
Partnership Inquiries

o: 210.696.8400
e: bennett.kennedy@missionpharmacal.com

Generic Pharmaceuticals Provider

BioComp Pharma®, Inc. (“BioComp”) is uniquely positioned to prosper in the ultra-competitive and increasingly generics-driven pharmaceutical industry. Through our experienced leadership team and exceptional core capabilities, we are poised for further growth and success with our continued addition of select partners and an active research and development pipeline. In addition, we offer services to other companies lacking the commercial and distribution infrastructure to bring a generic drug to market. Our team’s extensive pharmaceutical experience, coupled with low overhead costs and flexible operations, means we can distribute your products quickly with maximum profitability. 

Our complete turnkey and a la carte generics commercialization services include:

  • Labeling coordination and printing
  • Secure, environmentally controlled warehousing
  • Fully-licensed U.S. distribution and commercial launch
  • Electronic data interchange (EDI) capabilities 
  • National account and sales
    management and marketing
  • Accounting

Assurance of quality is paramount, so we only distribute products that are developed and manufactured in strict accordance with current Good Manufacturing Practice (cGMP) regulations.

BioComp Pharma

Year Founded
2008
Specialization
Focused on the development, sourcing, and commercialization of prescription generic drugs. We also specialize in offering these services to strategic partners, providing the full range of services in a flexible format to companies looking for commercial solutions.
Leadership
Pete Valko
Pete Valko
Chief Operating Officer
Partnership Inquiries

e: pvalko@biocomppharma.com
e: busdev@biocomppharma.com

Industry Leader In Transdermal Technology

ProSolus®, Inc. (“ProSolus”) has significantly improved the wearability of transdermal patches, offering more desirable, compact sizes that stay in place while working effectively. Few therapies on the market today are as effective or easy to use as ProSolus’ noninvasive and comfortable transdermal patches. Our state-of-the-art development and testing facility is capable of producing more than 10 million patches per year, and our primary focus lies in Pressure Sensitive Adhesive (PSA) technology and novel Hydrogel technology.

The ProSolus formulation team holds more than 35 patents in the transdermal and topical technology space and we have a proven track record of product commercialization. We are actively seeking strategic partnerships to out-license products and/or provide resources to commercialize products through:

  • Custom blending
  • Coating
  • Slitting
  • Die-cutting
  • Packaging
  • Full testing of products

Prosolus

Year Founded
2015
Specialization
Offers unrivaled expertise in the development and manufacturing of sophisticated and convenient transdermal/topical drug delivery systems (TDDS).
Leadership
Juan Mantelle
Juan Mantelle
Chief Operating Officer
Partnership Inquiries

o: 305.514.0271
c: 305.772.6652
e: jmantelle@prosoluspharma.com